LEO’s Enstilar Performs Well in Phase 3 Study of Adults With Stable Plaque Psoriasis in China
LEO Pharma’s Enstilar foam (LEO 90100) outperformed Daivobet ointment in a phase 3 trial of adults with stable plaque psoriasis in China, according to topline results. Enstilar –a calcipotriol/betamethasone cutaneous foam –is built on the active ingredients of Daivobet. Both are Leo Products. Once the full results of the new Phase 3 study are reported, […]